StockData
Vivos Therapeutics, Inc. logo

Vivos Therapeutics, Inc. (VVOS) income statement

VVOSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$0.08−0.00 (-4.64%)

Close on Nov 18, 2026Market cap $1.53MP/E –Yield –

Vivos Therapeutics, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
61.9%
Operating margin
-107.9%
Net margin
-121.8%
Return on equity, FY2025
-655.0%

Financial strength

Current ratio
0.21
Debt to equity
-2.13
Debt to assets
33.7%
Cash to current liabilities
8.7%

Valuation

P/E ratio
–
Price to sales
0.07
Price to book
–
Dividend yield
–

See a number that looks wrong?